Improving Lives Through Research
St. Charles Clinical Research is an independently owned company with over 40 years of combined experience in clinical trials. Our Friendly staff and personal approach provide the attention and professionalism crucial for the best patient experience.
C-Diff 1st Diagnosis or 1st Recurrence Treatment Study
Have you been diagnosed with C. difficile diarrhea? You may qualify if you are 18 years of age or older and have a first or second episode of C-diff infection (CDI.)
Study participants will be provided study medications, laboratory analyses, and follow up visits with our providers at no cost. A small stipend and help with transportation to and from the clinical research site may also be available.
C. Diff Treatment For Adults with Recurrent Infections
In a recent study, participants with recurrent C. diff who received CP101 after completing a round of antibiotics were significantly less likely to experience another episode of C. diff, compared to participants who received antibiotics alone. In the study, 74.5% of participants who received CP101 achieved a clinical cure, meaning they did not experience a recurrence of C. diff within 8 weeks of taking CP101.
CP101 is a microbiome therapy. The microbiome is the community of organisms that live in the intestinal tract.
More Studies Coming Soon
Screening for Colon Cancer
We will have more studies available, click below to join the waiting list.
St. Charles Clinical Research
6032 Weldon Spring Parkway
Weldon Spring, Mo. 63304
Pharmaceutical Study Experience